Personal tools

Coexpression cluster:C106: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0005886!plasma membrane!0.0440502824122341!9340;203413;250;360;10942;3708;7803;54946$GO:0005971!ribonucleoside-diphosphate reductase complex!0.0440502824122341!6240$GO:0004087!carbamoyl-phosphate synthase (ammonia) activity!0.0440502824122341!1373$GO:0046903!secretion!0.0440502824122341!25825;360;114879$GO:0008142!oxysterol binding!0.0440502824122341!114879$GO:0004086!carbamoyl-phosphate synthase activity!0.0440502824122341!1373$GO:0042985!negative regulation of amyloid precursor protein biosynthetic process!0.0440502824122341!25825$GO:0005737!cytoplasm!0.0440502824122341!57596;1373;9208;80325;2934;10942;3708;6240;7803;114879$GO:0048503!GPI anchor binding!0.0440502824122341!250;10942$GO:0042984!regulation of amyloid precursor protein biosynthetic process!0.0440502824122341!25825$GO:0005220!inositol 1,4,5-triphosphate-sensitive calcium-release channel activity!0.0440502824122341!3708$GO:0042983!amyloid precursor protein biosynthetic process!0.0440502824122341!25825$GO:0051014!actin filament severing!0.0440502824122341!2934$GO:0008095!inositol-1,4,5-triphosphate receptor activity!0.0440502824122341!3708$GO:0004035!alkaline phosphatase activity!0.0440502824122341!250$GO:0009049!aspartic-type signal peptidase activity!0.0458742318234648!25825$GO:0016728!oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor!0.0458742318234648!6240$GO:0004748!ribonucleoside-diphosphate reductase activity!0.0458742318234648!6240
|gostat_on_coexpression_clusters=GO:0005886!plasma membrane!0.0440502824122341!9340;203413;250;360;10942;3708;7803;54946$GO:0005971!ribonucleoside-diphosphate reductase complex!0.0440502824122341!6240$GO:0004087!carbamoyl-phosphate synthase (ammonia) activity!0.0440502824122341!1373$GO:0046903!secretion!0.0440502824122341!25825;360;114879$GO:0008142!oxysterol binding!0.0440502824122341!114879$GO:0004086!carbamoyl-phosphate synthase activity!0.0440502824122341!1373$GO:0042985!negative regulation of amyloid precursor protein biosynthetic process!0.0440502824122341!25825$GO:0005737!cytoplasm!0.0440502824122341!57596;1373;9208;80325;2934;10942;3708;6240;7803;114879$GO:0048503!GPI anchor binding!0.0440502824122341!250;10942$GO:0042984!regulation of amyloid precursor protein biosynthetic process!0.0440502824122341!25825$GO:0005220!inositol 1,4,5-triphosphate-sensitive calcium-release channel activity!0.0440502824122341!3708$GO:0042983!amyloid precursor protein biosynthetic process!0.0440502824122341!25825$GO:0051014!actin filament severing!0.0440502824122341!2934$GO:0008095!inositol-1,4,5-triphosphate receptor activity!0.0440502824122341!3708$GO:0004035!alkaline phosphatase activity!0.0440502824122341!250$GO:0009049!aspartic-type signal peptidase activity!0.0458742318234648!25825$GO:0016728!oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor!0.0458742318234648!6240$GO:0004748!ribonucleoside-diphosphate reductase activity!0.0458742318234648!6240
|id=C106
|id=C106
|ontology_enrichment_celltype=CL:0000066!4.76e-35!254;CL:0000223!2.71e-15!59;CL:0002076!8.78e-13!43;CL:0000076!3.98e-10!62;CL:0002251!1.57e-07!21
|ontology_enrichment_disease=DOID:305!5.19e-32!106;DOID:14566!3.04e-31!239;DOID:162!5.78e-30!235;DOID:0050687!9.86e-26!143;DOID:0050686!1.97e-09!137;DOID:1749!1.39e-08!14;DOID:299!5.06e-08!25
|ontology_enrichment_uberon=UBERON:0004119!5.38e-23!169;UBERON:0000925!5.38e-23!169;UBERON:0006595!5.38e-23!169;UBERON:0001007!3.65e-20!155;UBERON:0001555!3.65e-20!155;UBERON:0007026!3.65e-20!155;UBERON:0000077!1.20e-19!130;UBERON:0004921!1.87e-19!129;UBERON:0004185!1.87e-19!129;UBERON:0001041!4.20e-17!98;UBERON:0001004!4.37e-13!72;UBERON:0008947!1.85e-12!38;UBERON:0003258!1.85e-12!38;UBERON:0000065!3.79e-12!53;UBERON:0000072!9.54e-11!46;UBERON:0005911!1.66e-09!82;UBERON:0000466!1.68e-08!126;UBERON:0003104!6.77e-08!238;UBERON:0009142!6.77e-08!238;UBERON:0001737!1.19e-07!9;UBERON:0004175!2.44e-07!25;UBERON:0005153!2.65e-07!37;UBERON:0001048!3.18e-07!168;UBERON:0005178!6.57e-07!34;UBERON:0002224!6.57e-07!34
}}
}}

Revision as of 14:06, 21 May 2012


Full id: C106_Hep2_epitheloid_placenta_cervical_rectal_anaplastic_glassy



Phase1 CAGE Peaks

Hg19::chr10:47079076..47079087,+p@chr10:47079076..47079087
+
Hg19::chr11:125821678..125821700,+p1@ENST00000531193
p1@uc001qda.2
Hg19::chr11:2008416..2008424,-p@chr11:2008416..2008424
-
Hg19::chr11:3147806..3147811,-p7@OSBPL5
Hg19::chr11:3147835..3147866,-p2@OSBPL5
Hg19::chr11:3147868..3147894,-p3@OSBPL5
Hg19::chr11:3147896..3147911,-p5@OSBPL5
Hg19::chr11:3829763..3829832,+p2@PGAP2
Hg19::chr11:4116005..4116047,+p2@RRM1
Hg19::chr11:4116054..4116105,+p1@RRM1
Hg19::chr11:4116108..4116133,+p3@RRM1
Hg19::chr11:4128664..4128687,+p@chr11:4128664..4128687
+
Hg19::chr11:4142834..4142878,+p5@RRM1
Hg19::chr11:4154830..4154835,+p@chr11:4154830..4154835
+
Hg19::chr11:66742742..66742753,+p3@C11orf86
Hg19::chr12:51923800..51923807,+p@chr12:51923800..51923807
+
Hg19::chr12:9297545..9297579,+p@chr12:9297545..9297579
+
Hg19::chr13:107315737..107315759,+p1@ATP5G1P5
Hg19::chr14:100873293..100873312,+p1@ENST00000556411
Hg19::chr14:101034469..101034487,-p8@BEGAIN
Hg19::chr16:2867130..2867141,+p3@PRSS21
Hg19::chr16:2867201..2867209,+p2@PRSS21
Hg19::chr16:2867213..2867220,+p4@PRSS21
Hg19::chr16:2867231..2867246,+p1@PRSS21
Hg19::chr16:2867406..2867433,+p@chr16:2867406..2867433
+
Hg19::chr16:2867643..2867681,+p@chr16:2867643..2867681
+
Hg19::chr16:81040722..81040749,-p4@C16orf61
Hg19::chr16:87869840..87869849,+p@chr16:87869840..87869849
+
Hg19::chr16:87869864..87869878,+p@chr16:87869864..87869878
+
Hg19::chr16:87870800..87870828,-p@chr16:87870800..87870828
-
Hg19::chr16:87872769..87872797,-p@chr16:87872769..87872797
-
Hg19::chr16:87874486..87874492,-p@chr16:87874486..87874492
-
Hg19::chr17:79098633..79098647,-p@chr17:79098633..79098647
-
Hg19::chr17:9745568..9745583,+p8@GLP2R
Hg19::chr17:9745786..9745816,+p2@GLP2R
Hg19::chr17:9745823..9745837,+p4@GLP2R
Hg19::chr17:9745841..9745870,+p1@GLP2R
Hg19::chr18:33077964..33078002,-p2@INO80C
Hg19::chr18:48176351..48176356,+p@chr18:48176351..48176356
+
Hg19::chr18:48176398..48176416,+p@chr18:48176398..48176416
+
Hg19::chr18:51686438..51686469,-p@chr18:51686438..51686469
-
Hg19::chr19:3603267..3603275,+p@chr19:3603267..3603275
+
Hg19::chr19:3603296..3603307,+p@chr19:3603296..3603307
+
Hg19::chr19:52646236..52646246,+p2@ENST00000492641
Hg19::chr1:207262150..207262161,+p9@C4BPB
Hg19::chr1:207262170..207262212,+p1@C4BPB
Hg19::chr1:207262215..207262226,+p4@C4BPB
Hg19::chr1:207262232..207262254,+p2@C4BPB
Hg19::chr1:207262293..207262306,+p17@C4BPB
Hg19::chr1:207262478..207262493,+p14@C4BPB
Hg19::chr1:207262814..207262825,+p15@C4BPB
Hg19::chr1:207262856..207262880,+p8@C4BPB
Hg19::chr1:207263488..207263499,+p@chr1:207263488..207263499
+
Hg19::chr1:207263514..207263528,+p@chr1:207263514..207263528
+
Hg19::chr1:207263643..207263662,+p@chr1:207263643..207263662
+
Hg19::chr1:225653027..225653052,-p1@ENST00000428642
Hg19::chr21:42608536..42608555,+p12@BACE2
Hg19::chr21:44561726..44561765,-p@chr21:44561726..44561765
-
Hg19::chr21:44816823..44816837,-p@chr21:44816823..44816837
-
Hg19::chr21:46470677..46470687,-p@chr21:46470677..46470687
-
Hg19::chr2:121669351..121669360,-p@chr2:121669351..121669360
-
Hg19::chr2:20650796..20650830,+p1@ENST00000448241
Hg19::chr2:211421073..211421089,+p9@CPS1
Hg19::chr2:211427642..211427670,+p@chr2:211427642..211427670
+
Hg19::chr2:211469821..211469857,+p8@CPS1
Hg19::chr2:211543115..211543126,+p@chr2:211543115..211543126
+
Hg19::chr2:218871722..218871728,+p@chr2:218871722..218871728
+
Hg19::chr2:226378168..226378193,+p@chr2:226378168..226378193
+
Hg19::chr2:226378208..226378213,+p@chr2:226378208..226378213
+
Hg19::chr2:233243233..233243245,+p5@ALPP
Hg19::chr2:233243424..233243433,+p2@ALPP
Hg19::chr2:233243453..233243468,+p1@ALPP
Hg19::chr2:233243964..233243976,+p@chr2:233243964..233243976
+
Hg19::chr2:233244473..233244503,+p1@AK297894
Hg19::chr2:233244912..233244922,+p2@AK297894
Hg19::chr2:233246427..233246435,+p18@ALPP
Hg19::chr2:233246442..233246451,+p16@ALPP
Hg19::chr2:233246459..233246472,+p9@ALPP
Hg19::chr2:233246540..233246555,+p7@ALPP
Hg19::chr2:233246589..233246598,+p12@ALPP
Hg19::chr2:233246656..233246666,+p8@ALPP
Hg19::chr2:233246764..233246778,+p3@ALPP
Hg19::chr2:233246793..233246841,-p1@ENST00000441266
Hg19::chr2:233246828..233246839,+p4@ALPP
Hg19::chr2:233246932..233246943,+p6@ALPP
Hg19::chr2:233246988..233246995,+p@chr2:233246988..233246995
+
Hg19::chr2:233321333..233321358,+p@chr2:233321333..233321358
+
Hg19::chr2:233323834..233323845,+p@chr2:233323834..233323845
+
Hg19::chr2:233324172..233324183,+p@chr2:233324172..233324183
+
Hg19::chr2:233324211..233324229,-p@chr2:233324211..233324229
-
Hg19::chr2:238592039..238592054,+p4@LRRFIP1
Hg19::chr2:53732986..53732989,-p@chr2:53732986..53732989
-
Hg19::chr2:99389915..99389917,+p@chr2:99389915..99389917
+
Hg19::chr3:125775961..125775982,-p4@SLC41A3
Hg19::chr3:125775994..125776003,-p13@SLC41A3
Hg19::chr3:127395141..127395157,+p3@ABTB1
Hg19::chr3:4637757..4637784,+p7@ITPR1
Hg19::chr3:4637817..4637826,+p12@ITPR1
Hg19::chr4:123838984..123838995,-p@chr4:123838984..123838995
-
Hg19::chr4:123839002..123839016,-p@chr4:123839002..123839016
-
Hg19::chr4:134183951..134183960,-p4@ENST00000507172
Hg19::chr4:134184041..134184064,-p2@ENST00000507172
Hg19::chr4:134184268..134184272,-p1@ENST00000507172
Hg19::chr4:24322838..24322853,-p@chr4:24322838..24322853
-
Hg19::chr4:24323064..24323083,+p@chr4:24323064..24323083
+
Hg19::chr5:147582333..147582347,+p2@SPINK6
Hg19::chr5:147582348..147582361,+p5@SPINK6
Hg19::chr5:147582387..147582396,+p7@SPINK6
Hg19::chr5:147582412..147582423,+p9@SPINK6
Hg19::chr5:147582427..147582438,+p6@SPINK6
Hg19::chr5:147582468..147582479,+p3@SPINK6
Hg19::chr5:147582537..147582549,+p4@SPINK6
Hg19::chr5:147582568..147582578,+p8@SPINK6
Hg19::chr5:147582587..147582659,+p1@SPINK6
Hg19::chr5:147648268..147648281,+p2@SPINK13
Hg19::chr5:147648290..147648301,+p4@SPINK13
Hg19::chr5:147648304..147648364,+p1@SPINK13
Hg19::chr5:147648393..147648403,+p3@SPINK13
Hg19::chr5:17216221..17216259,-p@chr5:17216221..17216259
-
Hg19::chr5:37249111..37249143,+p@chr5:37249111..37249143
+
Hg19::chr6:64273353..64273372,+p@chr6:64273353..64273372
+
Hg19::chr6:64281927..64281943,+p17@PTP4A1
Hg19::chr6:64281946..64281977,+p12@PTP4A1
Hg19::chr6:64282122..64282131,+p40@PTP4A1
Hg19::chr6:64282212..64282247,+p19@PTP4A1
Hg19::chr7:100100722..100100732,-p@chr7:100100722..100100732
-
Hg19::chr7:158766986..158767004,+p@chr7:158766986..158767004
+
Hg19::chr7:54879745..54879759,-p@chr7:54879745..54879759
-
Hg19::chr7:54879785..54879794,-p@chr7:54879785..54879794
-
Hg19::chr7:54879818..54879835,-p@chr7:54879818..54879835
-
Hg19::chr7:54879838..54879849,-p@chr7:54879838..54879849
-
Hg19::chr8:101349850..101349862,+p1@ENST00000519566
Hg19::chr8:128231080..128231222,-p1@ENST00000500112
p1@uc003ysa.1
Hg19::chr8:128231226..128231265,-p2@ENST00000500112
p2@uc003ysa.1
Hg19::chr8:128231266..128231291,-p7@ENST00000500112
p7@uc003ysa.1
Hg19::chr8:128231299..128231352,-p3@ENST00000500112
p3@uc003ysa.1
Hg19::chr8:128231366..128231373,-p12@ENST00000500112
p12@uc003ysa.1
Hg19::chr8:128231385..128231401,-p8@ENST00000500112
p8@uc003ysa.1
Hg19::chr8:128231407..128231419,-p10@ENST00000500112
p10@uc003ysa.1
Hg19::chr8:128231438..128231455,-p6@ENST00000500112
p6@uc003ysa.1
Hg19::chr8:128231456..128231465,-p13@ENST00000500112
p13@uc003ysa.1
Hg19::chr8:128231471..128231489,-p4@ENST00000500112
p4@uc003ysa.1
Hg19::chr8:128231499..128231515,-p5@ENST00000500112
p5@uc003ysa.1
Hg19::chr8:128231669..128231680,-p9@ENST00000500112
p9@uc003ysa.1
Hg19::chr8:128231737..128231742,-p14@ENST00000500112
p14@uc003ysa.1
Hg19::chr8:128231755..128231758,-p11@ENST00000500112
p11@uc003ysa.1
Hg19::chr8:128232038..128232051,-p@chr8:128232038..128232051
-
Hg19::chr8:128232069..128232086,-p@chr8:128232069..128232086
-
Hg19::chr8:128235084..128235088,-p@chr8:128235084..128235088
-
Hg19::chr8:128238982..128239007,-p@chr8:128238982..128239007
-
Hg19::chr8:128239211..128239226,-p@chr8:128239211..128239226
-
Hg19::chr8:128240919..128240940,-p2@uc003ysb.2
Hg19::chr8:128241017..128241070,-p1@uc003ysb.2
Hg19::chr8:128241079..128241090,-p5@uc003ysb.2
Hg19::chr8:128241092..128241104,-p3@uc003ysb.2
Hg19::chr8:128241150..128241167,-p4@uc003ysb.2
Hg19::chr8:128241234..128241241,-p7@uc003ysb.2
Hg19::chr8:128265552..128265583,-p@chr8:128265552..128265583
-
Hg19::chr8:128433201..128433228,-p1@ENST00000501396
p1@ENST00000523825
p1@uc003ysc.1
p1@uc003ysd.1
Hg19::chr8:143781405..143781425,+p5@LY6K
Hg19::chr8:143781432..143781443,+p7@LY6K
Hg19::chr8:143781490..143781507,+p4@LY6K
Hg19::chr8:143781830..143781881,+p2@LY6K
Hg19::chr8:143781883..143781895,+p6@LY6K
Hg19::chr8:143781901..143781949,+p3@LY6K
Hg19::chr8:143782507..143782516,+p@chr8:143782507..143782516
+
Hg19::chr8:40071801..40071804,-p@chr8:40071801..40071804
-
Hg19::chr9:124088884..124088895,+p15@GSN
Hg19::chr9:124088907..124088937,+p5@GSN
Hg19::chr9:124088949..124088972,+p11@GSN
Hg19::chr9:133710199..133710220,-p@chr9:133710199..133710220
-
Hg19::chr9:33443566..33443587,-p16@AQP3
Hg19::chr9:84380797..84380800,+p@chr9:84380797..84380800
+
Hg19::chr9:9085941..9085944,+p@chr9:9085941..9085944
+
Hg19::chrX:115594126..115594143,-p1@CXorf61
Hg19::chrX:115594160..115594172,-p2@CXorf61
Hg19::chrX:115594195..115594200,-p3@CXorf61
Hg19::chrX:86868584..86868590,+p@chrX:86868584..86868590
+
Hg19::chrX:86868675..86868686,+p@chrX:86868675..86868686
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0005886plasma membrane0.0440502824122341
GO:0005971ribonucleoside-diphosphate reductase complex0.0440502824122341
GO:0004087carbamoyl-phosphate synthase (ammonia) activity0.0440502824122341
GO:0046903secretion0.0440502824122341
GO:0008142oxysterol binding0.0440502824122341
GO:0004086carbamoyl-phosphate synthase activity0.0440502824122341
GO:0042985negative regulation of amyloid precursor protein biosynthetic process0.0440502824122341
GO:0005737cytoplasm0.0440502824122341
GO:0048503GPI anchor binding0.0440502824122341
GO:0042984regulation of amyloid precursor protein biosynthetic process0.0440502824122341
GO:0005220inositol 1,4,5-triphosphate-sensitive calcium-release channel activity0.0440502824122341
GO:0042983amyloid precursor protein biosynthetic process0.0440502824122341
GO:0051014actin filament severing0.0440502824122341
GO:0008095inositol-1,4,5-triphosphate receptor activity0.0440502824122341
GO:0004035alkaline phosphatase activity0.0440502824122341
GO:0009049aspartic-type signal peptidase activity0.0458742318234648
GO:0016728oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor0.0458742318234648
GO:0004748ribonucleoside-diphosphate reductase activity0.0458742318234648



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen
epithelial cell4.76e-35254
endodermal cell2.71e-1559
endo-epithelial cell8.78e-1343
squamous epithelial cell3.98e-1062
epithelial cell of alimentary canal1.57e-0721
Disease
Ontology termp-valuen
carcinoma5.19e-32106
disease of cellular proliferation3.04e-31239
cancer5.78e-30235
cell type cancer9.86e-26143
organ system cancer1.97e-09137
squamous cell carcinoma1.39e-0814
adenocarcinoma5.06e-0825


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C106&oldid=1703661"